These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 26840566)
1. Overexpression of lipocalin 2 in human cervical cancer enhances tumor invasion. Chung IH; Wu TI; Liao CJ; Hu JY; Lin YH; Tai PJ; Lai CH; Lin KH Oncotarget; 2016 Mar; 7(10):11113-26. PubMed ID: 26840566 [TBL] [Abstract][Full Text] [Related]
2. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition. Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767 [TBL] [Abstract][Full Text] [Related]
3. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034 [TBL] [Abstract][Full Text] [Related]
4. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer. Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945 [TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer. Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells. Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308 [TBL] [Abstract][Full Text] [Related]
7. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma. Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590 [TBL] [Abstract][Full Text] [Related]
8. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling. Xu SH; Huang JZ; Xu ML; Yu G; Yin XF; Chen D; Yan GR J Pathol; 2015 Jun; 236(2):175-85. PubMed ID: 25678401 [TBL] [Abstract][Full Text] [Related]
9. Lipocalin 2 promotes breast cancer progression. Yang J; Bielenberg DR; Rodig SJ; Doiron R; Clifton MC; Kung AL; Strong RK; Zurakowski D; Moses MA Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3913-8. PubMed ID: 19237579 [TBL] [Abstract][Full Text] [Related]
11. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis. Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells. Yang X; Li S; Li W; Chen J; Xiao X; Wang Y; Yan G; Chen L Oncol Rep; 2013 Feb; 29(2):541-8. PubMed ID: 23165370 [TBL] [Abstract][Full Text] [Related]
13. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia. Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer. Kurozumi S; Alsaeed S; Orah N; Miligy IM; Joseph C; Aljohani A; Toss MS; Fujii T; Shirabe K; Green AR; Aleskandarany MA; Rakha EA Breast Cancer Res Treat; 2020 Feb; 179(3):557-564. PubMed ID: 31707510 [TBL] [Abstract][Full Text] [Related]
15. Lipocalin 2 induces the epithelial-mesenchymal transition in stressed endometrial epithelial cells: possible correlation with endometriosis development in a mouse model. Liao CJ; Li PT; Lee YC; Li SH; Chu ST Reproduction; 2014 Feb; 147(2):179-87. PubMed ID: 24194573 [TBL] [Abstract][Full Text] [Related]
16. Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop. Du ZP; Wu BL; Xie YM; Zhang YL; Liao LD; Zhou F; Xie JJ; Zeng FM; Xu XE; Fang WK; Li EM; Xu LY Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2240-50. PubMed ID: 26190820 [TBL] [Abstract][Full Text] [Related]
17. Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix. Wu CH; Ko JL; Chen SC; Lin YW; Han CP; Yang TY; Chien MH; Wang PH Gynecol Oncol; 2014 Feb; 132(2):474-82. PubMed ID: 24316309 [TBL] [Abstract][Full Text] [Related]
18. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition. Ma Y; Zheng X; Zhou J; Zhang Y; Chen K Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850 [TBL] [Abstract][Full Text] [Related]
19. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer. Huang W; Zhu S; Liu Q; Li C; Li L Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215 [TBL] [Abstract][Full Text] [Related]
20. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]